Relación coste-efectividad de la combinación rosuvastatina/ezetimiba frente a las combinaciones de simvastatina y atorvastatina con ezetimiba ara reducir el riesgo de eventos cardiovasculares

Cost-effectiveness analysis of rosuvastatin/ezetimibe combination compared with atorvastatin and simvastatin combined with ezetimibe in patients with high or very high cardiovascular risk, from the perspective of the Spanish National Health System

Authors: OLMO-QUINTANA, VICENTE; ZAMORA, BERNARDA; PINTÓ SALA, XAVIER; MARTÍ RAGUÉ, IGNASI; CORTÉS GIL, XAVIER; GARI PERIS, CARLA; ACEITUNO MATA, SUSANA

Journal: Revista Española de Economía de la Salud

Year: 2021

Outside URL

Subscribe to Outcomes´10

Name *

E-mail *

Todos los campos marcados con un * son obligatorios

Responsible for the data: Outcomes'10, s.l.u., Purpose: Sending commercial communications. Legitimation: Art. 6.1 Consent of the interested party. Recipient: No data is transferred unless expressly authorised. You may exercise your rights on data protection (access, rectification, opposition, deletion, automated decisions, limitation of treatment, portability) by email at dpo@outcomes10.com. Data will be retained for the time necessary to fulfill its purpose and derived responsibilities by current regulations and the deadlines in the applicable regulations on archives and documentation. In any case, you can request the protection of the Spanish Data Protection Agency through its website www.aepd.es/. In addition, you can consult more information on the privacy policy

I have read and accepted the privacy policy